![Stephen Dowd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Stephen Dowd
Anciens postes connus de Stephen Dowd
Sociétés | Poste | Début | Fin |
---|---|---|---|
RALLYBIO CORPORATION | Corporate Officer/Principal | 01/11/2021 | 01/09/2023 |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
GSK PLC | Corporate Officer/Principal | - | - |
Arecor Ltd.
![]() Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Formation de Stephen Dowd
University of Cambridge | Masters Business Admin |
University Of Dundee | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 6 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Masters Business Admin | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
GSK PLC | Health Technology |
RALLYBIO CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Arecor Ltd.
![]() Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Stephen Dowd
- Expérience